- Home
- VERU vs IROQ Comparison
VERU vs IROQ Comparison
Compare VERU & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- IROQ
- Stock Information
- Founded
- VERU 1971
- IROQ 1883
- Country
- VERU United States
- IROQ United States
- Employees
- VERU N/A
- IROQ N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- IROQ Savings Institutions
- Sector
- VERU Health Care
- IROQ Finance
- Exchange
- VERU Nasdaq
- IROQ Nasdaq
- Market Cap
- VERU 88.4M
- IROQ 79.7M
- IPO Year
- VERU 1990
- IROQ 2011
- Fundamental
- Price
- VERU $0.61
- IROQ $24.03
- Analyst Decision
- VERU Strong Buy
- IROQ
- Analyst Count
- VERU 2
- IROQ 0
- Target Price
- VERU $4.00
- IROQ N/A
- AVG Volume (30 Days)
- VERU 4.2M
- IROQ 1.3K
- Earning Date
- VERU 08-07-2025
- IROQ 04-29-2025
- Dividend Yield
- VERU N/A
- IROQ 1.65%
- EPS Growth
- VERU N/A
- IROQ 69.23
- EPS
- VERU N/A
- IROQ 1.05
- Revenue
- VERU $16,886,419.00
- IROQ $25,099,000.00
- Revenue This Year
- VERU N/A
- IROQ N/A
- Revenue Next Year
- VERU N/A
- IROQ N/A
- P/E Ratio
- VERU N/A
- IROQ $23.14
- Revenue Growth
- VERU 134.43
- IROQ 12.02
- 52 Week Low
- VERU $0.45
- IROQ $14.85
- 52 Week High
- VERU $1.42
- IROQ $25.76
- Technical
- Relative Strength Index (RSI)
- VERU 55.87
- IROQ 47.95
- Support Level
- VERU $0.61
- IROQ $23.86
- Resistance Level
- VERU $0.74
- IROQ $24.15
- Average True Range (ATR)
- VERU 0.06
- IROQ 0.16
- MACD
- VERU 0.01
- IROQ -0.05
- Stochastic Oscillator
- VERU 50.42
- IROQ 30.91
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.